Viewing Study NCT00021814



Ignite Creation Date: 2024-05-05 @ 11:23 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00021814
Status: COMPLETED
Last Update Posted: 2018-09-28
First Post: 2001-08-04

Brief Title: Medical Therapy of Prostatic Symptoms
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases NIDDK
Organization: National Institute of Diabetes and Digestive and Kidney Diseases NIDDK

Study Overview

Official Title: Medical Therapy of Prostatic Symptoms
Status: COMPLETED
Status Verified Date: 2018-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MTOPS
Brief Summary: The Medical Therapy of Prostatic Symptoms MTOPS is a clinical research study sponsored by the National Institutes of Health NIH The study will test whether the oral drugs finasteride Proscar and doxazosin Cardura alone or together can delay or prevent further worsening of symptoms in men with Benign Prostatic Hyperplasia BPH

MTOPS is the largest and longest study to simultaneously test whether these drugs can delay or prevent the clinical progression symptom worsening of BPH Seventeen US medical centers recruited 2931 men diagnosed with symptomatic BPH between December 1995 and March 1998 Study doctors will continue to follow these men through November 2001 on a quarterly basis In addition to the clinical progression of BPH MTOPS will include evaluations of prostate volume by ultrasound prostate biopsies among a subgroup of volunteers and quality of life
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
U01DK046472 NIH None httpsreporternihgovquickSearchU01DK046472